Mo1867 - Shorter Disease Duration is Associated with Higher Response Rates to Vedolizumab in Crohn's Disease but not Ulcerative Colitis: A Multi-Center Consortium Analysis
Faleck, David⋅Faleck, David⋅Winters, Adam⋅Winters, Adam⋅Chablaney, Shreya⋅Chablaney, Shreya⋅Shashi, Preeti⋅Shashi, Preeti⋅Meserve, Joseph⋅Meserve, Joseph⋅Weiss, Aaron⋅Weiss, Aaron⋅Aniwan, Satimai⋅Aniwan, Satimai⋅Koliani-Pace, Jenna L⋅Koliani-Pace, Jenna L⋅Kochhar, Gursimran⋅Kochhar, Gursimran⋅Boland, Brigid S⋅Boland, Brigid S⋅Singh, Siddharth⋅Singh, Siddharth⋅Hirten, Robert⋅Hirten, Robert⋅Shmidt, Eugenia⋅Shmidt, Eugenia⋅Lasch, Karen⋅Lasch, Karen⋅Luo, Michelle⋅Luo, Michelle⋅Bohm, Matthew⋅Bohm, Matthew⋅Sagi, Sashivar⋅Sagi, Sashivar⋅Fischer, Monika⋅Fischer, Monika⋅Hudesman, David⋅Hudesman, David⋅Chang, Shannon⋅Chang, Shannon⋅Lukin, Dana J⋅Lukin, Dana J⋅Keith, Sultan⋅Keith, Sultan⋅Swaminath, Arun⋅Swaminath, Arun⋅Gupta, Nitin⋅Gupta, Nitin⋅Siegel, Corey A⋅Siegel, Corey A⋅Shen, Bo⋅Shen, Bo⋅Sandborn, William J⋅Sandborn, William J⋅Kane, Sunanda V⋅Kane, Sunanda V⋅Loftus, Edward V⋅Loftus, Edward V⋅Sands, Bruce E⋅Sands, Bruce E⋅Colombel, Jean Frederic⋅Colombel, Jean Frederic⋅Dulai, Parambir⋅Dulai, Parambir⋅Ungaro, Ryan C and Ungaro, Ryan C
Gastroenterology, vol. 154, (no. 6), pp. S-832, May 2018. | Journal Article